Fig. 4From: A phase 1 evaluation of the pharmacokinetic/pharmacodynamic interaction of the anti-malarial agents KAF156 and piperaquineArithmetic mean (SD) QTcF change time profile from pre-dose profile by treatment. Combination is indicated by the solid line with circles, KAF156 monotherapy by the dotted line with squares, and piperaquine monotherapy by the dash-dot line with cross marksBack to article page